Asciminib Hydrochloride
Spécifications
2119669-71-3Numéro CAS
188-654-4Numéro CE
N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide;hydrochlorideNom IUPAC
C20H19Cl2F2N5O3Formule chimique
486.3 g/molMasse molaire
Asciminib hydrochloride; 2119669-71-3; ABL001-AAA; C5U34S9XFV; RefChem:58303; N-(4-(Chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)pyridine-3-carboxamidehydrogen Chloride (1/1); Asciminib (hydrochloride); Asciminib HCl; Scemblix; Asciminib hydrochloride [USAN]; UNII-C5U34S9XFV; 3-Pyridinecarboxamide, N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxy-1-pyrrolidinyl)-5-(1H-pyrazol-3-yl)-, hydrochloride (1:1); N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide monohydrochloride; N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide;hydrochloride; Scemblix (TN); orb1686815; orb1940871; CHEMBL4297220; SCHEMBL22656445; SCHEMBL29521537; WLZ3771; Asciminib hydrochloride (JAN/USAN); ASCIMINIB HYDROCHLORIDE [JAN]; HY-104010A; ASCIMINIB HYDROCHLORIDE [WHO-DD]; DA-71060; MS-29032; ASCIMINIB HYDROCHLORIDE [ORANGE BOOK]; D11404; T63226; A724092; (R)-N-(4-(chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-3-yl)nicotinamide hydrochloride; (R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide hydrochlorideSynonymes
Produits contenant Asciminib Hydrochloride
셈블릭스정40밀리그램(애시미닙염산염)셈블릭스정20밀리그램(애시미닙염산염)セムブリックス錠20mg／セムブリックス錠40mgSCEMBLIX 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULASCEMBLIX 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULASCEMBLIX 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULASCEMBLIX 40 mg, comprimés pelliculésSCEMBLIX 20 mg, comprimés pelliculésAsciminib HCL
